Changes in gene expression linked to methamphetamine-induced dopaminergic neurotoxicity

Journal of Neuroscience

Volumn 22, Issue 1, 2002, Pages 274-283

  Xie, Tao ^a   Tong, Liqiong ^a   Barrett, Tanya ^b   Yuan, Jie ^a   Hatzidimitriou, George ^a   McCann, Una D ^a   Becker, Kevin G ^b   Donovan, David M ^b   Ricaurte, George A ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Amphetamines; Dopamine; Microarray; Neurodegeneration cytochrome c oxidase; Neurotoxicity

Indexed keywords

CYCLOHEXIMIDE; CYTOCHROME C OXIDASE; DACTINOMYCIN; GENE PRODUCT; METHAMPHETAMINE; PHOSPHOGLYCERATE MUTASE; PROTON; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SODIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; ENERGY METABOLISM; GENE EXPRESSION; IN SITU HYBRIDIZATION; ION TRANSPORT; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; NORTHERN BLOTTING; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTON SODIUM EXCHANGE; TEMPERATURE SENSITIVITY;

EID: 0036138937     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-01-00274.2002     Document Type: Article

References (52)

1. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: Pharmacological profile of protective and nonprotective agents
2. Low environmental temperatures or pharmacologic agents that produce hyperthermia decrease methamphetamine neurotoxicity in mice
3. Methamphetamine-induced dopaminergic toxicity in mice. Role of environmental temperature and pharmacological agents
4. Amphetamine-induced behavior, dopamine release, and c-fos mRNA expression: Modulation by environmental novelty
5. Environmental modulation of amphetamine-induced c-fos expression in D1 versus D2 striatal neurons
6. A murine dopamine neuron-specific cDNA library and microarray: Increased COX I expression during methamphetamine neurotoxicity
7. Adaptive changes in the nigrostriatal pathway in response to increased 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration in the mouse
8. Sequence and gene organization of mouse mitochondrial DNA
9. The influence of environmental temperature on the transient effect of methamphetamine on dopamine levels and dopamine release in striatum
10. Further studies of the role of hyperthermia in methamphetamine neurotoxicity
11. Central administration of methamphetamine synergizes with metabolic inhibition to deplete striatal monoamines
12. Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration
13. Temporal profiling of methamphetamine-induced changes in gene expression in the mouse brain: Evidence from cDNA array
14. Effects of 2-deoxy-D-glucose on methamphetamine-induced dopamme and serotonin neurotoxicity
15. ++ exchange potentiate methamphetamine-induced dopamine neurotoxicity: Possible role of ionic dysregulation in methamphetamine neurotoxicity
16. Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine
17. Comparative distribution of mRNAs for glutamic acid decarboxylase, tyrosine hydroxylase, and tachykinins in the basal ganglia: An in situ hybridization study in the rodent brain
18. Role for protein synthesis in the neurotoxic effects of methamphetamine in mice and rats
19. Role of dopamine transporter in methamphetamine-induced neurotoxicity: Evidence from mice lacking the transporter
20. Neurochemical mechanisms of toxicity
21. Compartmental organization and chemical profile of dopaminergic and GABA neurons in the substantia nigra of the rat
22. Altered serotonin innervation patterns in the forebrain of monkeys treated with (+)3,4-methylenedioxymethamphetamine seven years previously: Factors influencing abnormal recovery
23. A rapid method for the regional dissection of the rat brain
24. Metabolic effects of nigrostriatal denervation in basal ganglia
25. Nicotinamide attenuates methamphetamine-induced striatal dopamine depletion in rats
26. Differential gene expression in methamphetamine neurotoxicity identified using cDNA arrays
27. Simultaneous isotopic and nonisotopic in situ hybridization histochemistry with cRNA probes
28. Toward the development of an in vitro model of methamphetamine-induced dopamine nerve terminal toxicity
29. A robust increase in expression of arc gene, an effector immediate early gene, in the rat brain after acute and chronic methamphetamine administration
30. Methamphetamine-induced hyperthermia in mice: Examination of dopamine depletion and heat-shock protein induction
31. Metabolic changes after injection of quinolinic acid or 6-hydroxydopamine in the rat striatum: A time-course study using cytochrome oxidase and glycogene phosphorylase a histochemistry
32. Evidence for and mechanism of action of neurotoxicity of amphetamine related compounds
33. Protein measurements with Folin phenol reagent
34. Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons
35. The effects of monoamine uptake inhibitors and methamphetamine on neostriatal 6-hydroxydopamine (6-OH DA) formation, short-term monoamine depletions and locomotor activity in the rat
36. Induction of neurotensin and c-fos mRNA in distinct subregions of rat neostriatum after acute methamphetamine: Comparison with acute haloperidol effects
37. Environment, stress- and drug-induced alterations in body temperature affect the neurotoxicity of the substituted amphetamines in the C57BL/6J mouse
38. Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity
39. Functional activity of zona incerta neurons is altered after nigrostriatal denervation in hemiparkinsonian rats
40. The effects of amfonelic acid, a dopamine uptake inhibitor, on methamphetamine-induced dopaminergic terminal degeneration and astrocytic response in rat striatum
41. Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain
42. Nerve terminal degeneration after a single injection of D-amphetamine in iprindole-treated rats: Relation to selective long-lasting dopamine depletion
43. Lasting effects of (±)3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: Neurochemical observations
44. Methamphetamine-induced neurotoxicity is associated with increased striatal AP-1 DNA-binding activity in mice
45. Acute amphetamine or methamphetamine alters opiod peptide mRNA expression in rat striatum
46. Substrates of energy metabolism attenuate methamphetamine-induced neurotoxicity in striatum
47. Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic and electrophysiological measurements
48. Dose-dependent alteration in zif/268 and preprodynorphin mRNA expression induced by amphetamine or methamphetamine in rat forebrain
49. Analysis of gene expression in multiple sclerosis lesions using cDNA microarrays
50. Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription
51. Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: Implications for methamphetamine-induced dopaminergic neurotoxicity
52. Evidence against an essential role of endogenous brain dopamine in methamphetamine-induced dopaminergic neurotoxicity